On August 5, 2025, Amgen Inc. reported its second quarter 2025 unaudited financial results, including key non-GAAP measures, highlighting its ongoing business performance and liquidity. This report reiterates Amgen's focus on providing supplementary financial insights to investors regarding its operations and performance.